MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.11.2025
AgeX Therapeutics EV/EBITDA 2011-2026 | AGE
EV/EBITDA Jährlich AgeX Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.85 | -7.11 | -4.46 | -12.2 | - | -6.81 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.85 | -12.2 | -6.48 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B |  USA |
 |
Apellis Pharmaceuticals
APLS
|
-6.39 | $ 20.2 | -2.42 % | $ 2.55 B | USA |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.82 | -2.95 % | $ 4.47 M | China |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Axsome Therapeutics
AXSM
|
-8.03 | $ 166.62 | 0.14 % | $ 8.29 B | USA |
 |
AbCellera Biologics
ABCL
|
9.24 | $ 3.74 | -2.23 % | $ 1.12 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Codexis
CDXS
|
-100 | $ 0.98 | -3.72 % | $ 71.9 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 23.95 | 0.29 % | $ 2.93 B | USA |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
Corvus Pharmaceuticals
CRVS
|
0.244 | $ 17.56 | -1.84 % | $ 843 M | USA |
 |
Champions Oncology
CSBR
|
77 | $ 5.98 | -1.48 % | $ 81.7 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-53 | $ 17.77 | -2.09 % | $ 456 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
Exelixis
EXEL
|
18.1 | $ 40.92 | -0.27 % | $ 11.1 B | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-2.14 | $ 25.91 | -3.54 % | $ 694 M | USA |
 |
Galectin Therapeutics
GALT
|
-1.92 | $ 2.9 | -5.39 % | $ 181 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | Canada |
 |
Galapagos NV
GLPG
|
-26.5 | $ 33.14 | -2.79 % | $ 2.69 B |  Belgium |
 |
Greenwich LifeSciences
GLSI
|
-47.7 | $ 27.35 | -0.15 % | $ 356 M | USA |
|
Galecto
GLTO
|
-0.349 | $ 29.97 | -0.27 % | $ 796 M |  Danmark |
 |
Genmab A/S
GMAB
|
2.7 | $ 27.66 | -6.71 % | $ 17.5 B | Danmark |
 |
Gossamer Bio
GOSS
|
-3.32 | $ 0.46 | 8.21 % | $ 70.2 M | USA |
 |
GeoVax Labs
GOVX
|
-0.113 | $ 1.54 | -1.6 % | $ 2.8 M | USA |
 |
Grifols, S.A.
GRFS
|
13.7 | $ 8.61 | -5.28 % | $ 6.83 B |  Spain |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
Halozyme Therapeutics
HALO
|
17.2 | $ 68.68 | -1.68 % | $ 8.23 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Hoth Therapeutics
HOTH
|
0.527 | $ 1.0 | -2.34 % | $ 6.38 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
Harmony Biosciences Holdings
HRMY
|
23 | $ 28.29 | -2.11 % | $ 1.63 B | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-8.96 | $ 3.2 | -4.19 % | $ 1.15 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-5.08 | $ 28.5 | -2.41 % | $ 1.65 B | USA |
 |
ImmuCell Corporation
ICCC
|
23.1 | $ 6.24 | -4.66 % | $ 51 M | USA |
 |
IDEAYA Biosciences
IDYA
|
-11.4 | $ 35.14 | 6.34 % | $ 3.11 B | USA |
 |
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |